These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17250920)

  • 1. Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain.
    Kreuter J; Hekmatara T; Dreis S; Vogel T; Gelperina S; Langer K
    J Control Release; 2007 Mar; 118(1):54-8. PubMed ID: 17250920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain.
    Michaelis K; Hoffmann MM; Dreis S; Herbert E; Alyautdin RN; Michaelis M; Kreuter J; Langer K
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1246-53. PubMed ID: 16554356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB).
    Ulbrich K; Hekmatara T; Herbert E; Kreuter J
    Eur J Pharm Biopharm; 2009 Feb; 71(2):251-6. PubMed ID: 18805484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.
    Zensi A; Begley D; Pontikis C; Legros C; Mihoreanu L; Wagner S; Büchel C; von Briesen H; Kreuter J
    J Control Release; 2009 Jul; 137(1):78-86. PubMed ID: 19285109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The delivery of loperamide to the brain by using polybutyl cyanoacrylate nanoparticles].
    Aliautdin RN; Petrov VE; Langer K; Berthold A; Kreuter J; Kharkevich DA
    Eksp Klin Farmakol; 1998; 61(1):17-20. PubMed ID: 9575405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
    Chen YC; Hsieh WY; Lee WF; Zeng DT
    J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters.
    Gelperina S; Maksimenko O; Khalansky A; Vanchugova L; Shipulo E; Abbasova K; Berdiev R; Wohlfart S; Chepurnova N; Kreuter J
    Eur J Pharm Biopharm; 2010 Feb; 74(2):157-63. PubMed ID: 19755158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the insulin receptor: nanoparticles for drug delivery across the blood-brain barrier (BBB).
    Ulbrich K; Knobloch T; Kreuter J
    J Drug Target; 2011 Feb; 19(2):125-32. PubMed ID: 20387992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport across the blood-brain barrier using albumin nanoparticles.
    Park K
    J Control Release; 2009 Jul; 137(1):1. PubMed ID: 19427883
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123.
    Tosi G; Costantino L; Rivasi F; Ruozi B; Leo E; Vergoni AV; Tacchi R; Bertolini A; Vandelli MA; Forni F
    J Control Release; 2007 Sep; 122(1):1-9. PubMed ID: 17651855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.
    Kreuter J; Shamenkov D; Petrov V; Ramge P; Cychutek K; Koch-Brandt C; Alyautdin R
    J Drug Target; 2002 Jun; 10(4):317-25. PubMed ID: 12164380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human serum albumin nanoparticles modified with apolipoprotein A-I cross the blood-brain barrier and enter the rodent brain.
    Zensi A; Begley D; Pontikis C; Legros C; Mihoreanu L; Büchel C; Kreuter J
    J Drug Target; 2010 Dec; 18(10):842-8. PubMed ID: 20849354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle.
    Lu W; Wan J; She Z; Jiang X
    J Control Release; 2007 Mar; 118(1):38-53. PubMed ID: 17240471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution.
    Tosi G; Vergoni AV; Ruozi B; Bondioli L; Badiali L; Rivasi F; Costantino L; Forni F; Vandelli MA
    J Control Release; 2010 Jul; 145(1):49-57. PubMed ID: 20338201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HI 6 human serum albumin nanoparticles--development and transport over an in vitro blood-brain barrier model.
    Dadparvar M; Wagner S; Wien S; Kufleitner J; Worek F; von Briesen H; Kreuter J
    Toxicol Lett; 2011 Sep; 206(1):60-6. PubMed ID: 21726608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier.
    Wohlfart S; Khalansky AS; Gelperina S; Begley D; Kreuter J
    J Control Release; 2011 Aug; 154(1):103-7. PubMed ID: 21616104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles.
    Kurakhmaeva KB; Djindjikhashvili IA; Petrov VE; Balabanyan VU; Voronina TA; Trofimov SS; Kreuter J; Gelperina S; Begley D; Alyautdin RN
    J Drug Target; 2009 Sep; 17(8):564-74. PubMed ID: 19694610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles.
    Alyautdin RN; Petrov VE; Langer K; Berthold A; Kharkevich DA; Kreuter J
    Pharm Res; 1997 Mar; 14(3):325-8. PubMed ID: 9098875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles.
    Gao K; Jiang X
    Int J Pharm; 2006 Mar; 310(1-2):213-9. PubMed ID: 16426779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and therapeutic efficacy of polysorbate-80-coated amphotericin B/PLA-b-PEG nanoparticles.
    Ren T; Xu N; Cao C; Yuan W; Yu X; Chen J; Ren J
    J Biomater Sci Polym Ed; 2009; 20(10):1369-80. PubMed ID: 19622277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.